Cormedix Inc (CRMD)
10.33
-0.41
(-3.82%)
USD |
NASDAQ |
Nov 21, 16:00
10.33
0.00 (0.00%)
Pre-Market: 20:00
Cormedix Profit Margin (Quarterly): -24.24% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -24.24% |
| June 30, 2024 | -1.76K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -27.64K% |
| September 30, 2022 | -100.5K% |
| June 30, 2022 | -35.78K% |
| March 31, 2022 | -92.12K% |
| December 31, 2021 | -13.81K% |
| September 30, 2021 | -22.50K% |
| June 30, 2021 | -56.56K% |
| March 31, 2021 | -8.18K% |
| December 31, 2020 | -10.93K% |
| September 30, 2020 | -7.10K% |
| June 30, 2020 | -23.00K% |
| March 31, 2020 | -7.50K% |
| December 31, 2019 | -21.41K% |
| September 30, 2019 | -8.84K% |
| June 30, 2019 | -1.97K% |
| Date | Value |
|---|---|
| March 31, 2019 | -3.16K% |
| December 31, 2018 | |
| September 30, 2018 | -2.75K% |
| June 30, 2018 | -113.3K% |
| March 31, 2018 | -43.88K% |
| December 31, 2017 | -11.14K% |
| September 30, 2017 | -16.30K% |
| June 30, 2017 | -3.78K% |
| March 31, 2017 | -19.20K% |
| December 31, 2016 | -5.26K% |
| September 30, 2016 | -20.53K% |
| June 30, 2016 | -29.60K% |
| March 31, 2016 | -9.94K% |
| December 31, 2015 | -16.85K% |
| September 30, 2015 | -13.04K% |
| June 30, 2015 | -3.45K% |
| March 31, 2015 | -17.58K% |
| December 31, 2014 | -2.61K% |
| September 30, 2014 | -9.60K% |
| June 30, 2014 | |
| March 31, 2014 | -137.0K% |
| December 31, 2013 | -171.7K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-100.5K%
Minimum
Sep 2022
-24.24%
Maximum
Sep 2024
-28.59K%
Average
-21.41K%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Rockwell Medical Inc | 5.88% |
| Axogen Inc | -3.82% |
| Aquestive Therapeutics Inc | -84.99% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.96% |
| Return on Assets | -61.23% |
| Return on Invested Capital | -72.96% |
| Gross Profit Margin (Quarterly) | 94.01% |
| Operating Margin (Quarterly) | -28.70% |
| Return on Net Operating Assets | -404.7% |